- Home
- TWO vs QURE Comparison
TWO vs QURE Comparison
Compare TWO & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWO
- QURE
- Stock Information
- Founded
- TWO 2009
- QURE 1998
- Country
- TWO United States
- QURE Netherlands
- Employees
- TWO N/A
- QURE N/A
- Industry
- TWO Real Estate Investment Trusts
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- TWO Real Estate
- QURE Health Care
- Exchange
- TWO Nasdaq
- QURE Nasdaq
- Market Cap
- TWO 1.0B
- QURE 866.3M
- IPO Year
- TWO 2009
- QURE 2007
- Fundamental
- Price
- TWO $9.62
- QURE $58.05
- Analyst Decision
- TWO Buy
- QURE Strong Buy
- Analyst Count
- TWO 8
- QURE 12
- Target Price
- TWO $12.50
- QURE $69.67
- AVG Volume (30 Days)
- TWO 1.9M
- QURE 7.7M
- Earning Date
- TWO 10-27-2025
- QURE 11-04-2025
- Dividend Yield
- TWO 16.22%
- QURE N/A
- EPS Growth
- TWO N/A
- QURE N/A
- EPS
- TWO N/A
- QURE N/A
- Revenue
- TWO $257,735,000.00
- QURE $14,337,000.00
- Revenue This Year
- TWO N/A
- QURE N/A
- Revenue Next Year
- TWO N/A
- QURE $287.72
- P/E Ratio
- TWO N/A
- QURE N/A
- Revenue Growth
- TWO N/A
- QURE N/A
- 52 Week Low
- TWO $9.49
- QURE $5.35
- 52 Week High
- TWO $14.28
- QURE $65.14
- Technical
- Relative Strength Index (RSI)
- TWO 43.08
- QURE 67.52
- Support Level
- TWO $9.65
- QURE $58.12
- Resistance Level
- TWO $9.92
- QURE $65.14
- Average True Range (ATR)
- TWO 0.21
- QURE 4.20
- MACD
- TWO -0.02
- QURE -0.71
- Stochastic Oscillator
- TWO 15.75
- QURE 58.51
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.